Related Experiment Video
Updated: Jul 6, 2026
07:08
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Genotoxicity studies on green tea catechin
1Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan.
Summary
Green tea catechins showed mixed results in genotoxicity tests. While in vitro assays indicated potential concerns, in vivo studies found no significant genotoxic effects, suggesting safety for consumers.
Area of Science:
- Pharmacology
- Toxicology
- Molecular Biology
Background:
- Tea catechins are widely recognized for their health benefits.
- Genotoxicity assessment is crucial for evaluating the safety of dietary compounds like green tea catechins.
- Understanding the genotoxic potential informs risk assessment for human consumption.
Purpose of the Study:
- To evaluate the genotoxic potential of a green tea catechin preparation.
- To determine if green tea catechins pose a genotoxic risk using a battery of in vitro and in vivo assays.
- To correlate genotoxicity findings with epidemiological data on tea consumption and cancer prevention.
Main Methods:
- Bacterial reverse mutation assay (Ames test).
- In vitro chromosomal aberration assay in Chinese hamster lung (CHL/IU) cells.
- In vitro mouse lymphoma L5178Y/tk assay.
- In vivo bone marrow micronucleus (MN) assay in mice and rats.
Main Results:
- The Ames test showed no significant increase in revertant colonies.
- Positive responses were observed in the in vitro chromosomal aberration and mouse lymphoma assays.
- No significant increase in micronucleated polychromatic erythrocytes (MNPCE) was detected in vivo, even at high doses (2000mg/kg).
Conclusions:
- Despite some positive in vitro findings, the in vivo genotoxicity studies indicate a lack of significant genotoxic concern for green tea catechins.
- The results align with epidemiological data suggesting a chemopreventive role for tea catechins.
- Green tea catechin is considered safe under anticipated conditions of use regarding genotoxicity.
More Related Videos
10:35Study on the Metabolism of Six Systemic Insecticides in a Newly Established Cell Suspension Culture Derived from Tea (Camellia Sinensis L.) Leaves
Published on: June 15, 2019
08:25Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...